US judge blocks lethal injection drug combo as

Image
AFP Chicago
Last Updated : Jan 26 2017 | 11:42 PM IST
Citing mounting evidence from recent US executions, a federal judge today blocked the use of lethal injections to put to death three inmates, saying a proposed cocktail of drugs was unconstitutional.
Federal Magistrate Judge Michael Merz of Ohio focused heavily on the use of one of the drugs, midazolam, citing evidence from multiple other state executions that the drug insufficiently sedated inmates, likely leading to suffering during their executions.
Lawyers for three Ohio death row inmates claimed such suffering violated the US Constitution's Eighth Amendment prohibition against cruel and unusual punishment. Judge Merz sided with that argument, saying the proposed three-drug lethal injection cocktail "creates a substantial risk of serious harms."
Raymond Tibbetts, Ronald Phillips and Gary Otte were all scheduled to be executed by Ohio between February and April, but Merz granted a preliminary injunction barring the state from using a combination of midazolam, a paralytic agent or potassium chloride, which stops the heart.
In a 119-page ruling, the judge cited recent executions in Ohio, Alabama, Arizona and elsewhere, where inmates receiving midazolam as the first drug in a lethal injection cocktail appeared to remain conscious for a substantial period of time.
Ohio halted executions after the 2014 lethal injection of Dennis McGuire using midazolam, during which the inmate appeared to snort and gasp. Judge Merz pointed to witness testimony from that execution, including from Columbus Dispatch reporter Alan Johnson, who has witnessed 20 executions in total.
"McGuire began coughing, gasping, choking in a way that I had not seen before at any execution... Frankly, that went on for 12 to 13 minutes," the judge quoted Johnson as saying.
The state countered that the revised dosage of midazolam would be 50 times stronger. But the judge pointed to expert testimony offered by the plaintiffs that midazolam was not an adequate substitute for general anesthesia drugs.
Its use in executions is "contrary to sound medical or scientific reasoning," testified Craig Stevens, professor of pharmacology at Oklahoma State University, according to the court.
States have struggled to find adequate supplies of lethal injection drugs, as pharmaceutical companies have restricted the use of their drugs for executions.
Court challenges have ensued as states have tried new drug cocktails.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 26 2017 | 11:42 PM IST

Next Story